AMARILLO, Texas (AP) — A federal ... Judge Matthew Kacsmaryk is weighing a lawsuit from Christian conservatives aimed at overturning the Food and Drug Administration's more than 2-decade-old ...

The case, filed in Amarillo, challenges the Food and Drug Administration’s approval of mifepristone. There is a lawsuit that could be decided as early as this week that, if successful, would ...

Mifepristone was authorized by the U.S. Food and Drug Administration in 2000. In the U.S., the drugs are approved up to 10 weeks' gestation, although the World Health Organization says they can be ...

Texas judges produced “more than half” of all universal injunctions issued during the terms of former Presidents Barack Obama ...

Court officials in Amarillo, Texas, have released the transcript from this week's closely watched hearing in a federal lawsuit that could curb access nationwide to a drug that's used in nearly all ...

For about four hours of arguments, a federal judge in Texas asked questions that suggested he is seriously considering undoing the US Food and Drug Administration’s approval of a medication ...

The process by which the Food and Drug Administration approved the medicated abortion pill mifepristone more than 20 years ago appeared to be among the issues weighing on U.S. District Court Judge … ...

The Supreme Court sent the case back to Amarillo. Those suing want to alter their suit while the Food and Drug Administration and the Department of Health and Human Services are asking Judge ...

Washington — The Trump administration on Monday urged a federal district court to dismiss a lawsuit challenging the Food and Drug Administration's actions expanding access to the widely used ...

A judge in Texas ruled Thursday that three other states can move ahead with their effort to roll back federal rules and make it harder for people across the U.S. to access the abortion drug ...

A group of anti-abortion doctors filed a lawsuit to revoke the Food and Drug Administration’s approval of mifepristone, which the U.S. Supreme Court ultimately rejected.